Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Tuberous Sclerosis 3Seizures 2Lennox Gastaut Syndrome 2Epilepsies, Myoclonic 2Prostatic Neoplasms 1Neoplasms 1Marijuana Abuse 1Liver Cirrhosis 1Glioblastoma 1Carcinoma, Intraductal, Noninfiltrating 1Cancer Pain 1Breast Carcinoma In Situ 1Behavior 1

Interventions

Tamoxifen 7Specimen Handling 7exemestane 3Letrozole 3Anastrozole 3Radiotherapy, Intensity-Modulated 2Radiotherapy, Conformal 2Radiation Dose Hypofractionation 2Biopsy 2ruxolitinib 1poly ICLC 1fezolinetant 1elacestrant 1Testosterone 1Surveys and Questionnaires 1Surgical Procedures, Operative 1Selective Estrogen Receptor Modulators 1Radiotherapy 1Radiation 1Protons 1Proton Therapy 1Omacor 1Neoadjuvant Therapy 1Multicenter Studies as Topic 1Metformin 1Medicare 1Mastectomy, Segmental 1Mastectomy 1Magnetic Resonance Spectroscopy 1High-Energy Shock Waves 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Intraductal, Noninfiltrating × Cannabidiol × 90 days × Clear all
NCT06538389 2026-04-30

High Cannabidiol Plant Extract (BRC-001) to Improve Aromatase Inhibitor-Induced Arthralgia in Women With Breast Cancer

City of Hope Medical Center

Phase 2 Recruiting
36 enrolled
Breast

Breast Carcinoma In Situ, Carcinoma, Intraductal, Noninfiltrating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡